Literature DB >> 22937491

Impact of SYNTAX score on 1-year clinical outcomes in patients undergoing percutaneous coronary intervention for unprotected left main coronary artery.

Tsuyoshi Nozue, Ryo Kamijima, Taku Iwaki, Ichiro Michishita.   

Abstract

SYNTAX score is an angiographic scoring system that was developed to quantify the number, complexity, and location of lesions in patients undergoing coronary revascularization. Up to now, the impact of SYNTAX score on clinical outcomes in patients undergoing percutaneous coronary intervention (PCI) for unprotected left main coronary artery (LMCA) lesions has not been fully examined. Therefore, we evaluate the usefulness of the SYNTAX score and identify the cutoff value of this score to predict 1-year clinical outcomes in patients undergoing PCI for unprotected LMCA lesions. This was a single-center retrospective study that included 49 consecutive patients undergoing elective PCI for unprotected LMCA lesions. We calculated the SYNTAX score and examined the correlations between this score and 1-year clinical outcomes. Major adverse cardiac events (MACE) occurred in 12 patients (24%): target lesion revascularization in 9 patients (18%), myocardial infarction in 2 (4%), and cardiac death in 1 (2%). The frequency of MACE was significantly higher in the intermediate (47%) or high score group (50%) than in the low score group (4%). Furthermore, the SYNTAX score was significantly higher in the MACE group than in the non-MACE group (31 vs. 22, p = 0.008). Receiver-operating characteristic curve showed that the SYNTAX score exhibited 83% sensitivity and 76% specificity for predicting the development of MACE at a cutoff value 26. These results demonstrate that the SYNTAX score could be a useful tool to predict 1-year clinical outcomes in patients undergoing elective PCI for unprotected LMCA lesions.

Entities:  

Keywords:  Coronary artery disease; SYNTAX score; left main coronary artery; percutaneous coronary intervention

Year:  2012        PMID: 22937491      PMCID: PMC3427976     

Source DB:  PubMed          Journal:  Am J Cardiovasc Dis        ISSN: 2160-200X


  20 in total

1.  ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention).

Authors:  Sidney C Smith; Ted E Feldman; John W Hirshfeld; Alice K Jacobs; Morton J Kern; Spencer B King; Douglass A Morrison; William W O'Neill; Hartzell V Schaff; Patrick L Whitlow; David O Williams; Elliott M Antman; Sidney C Smith; Cynthia D Adams; Jeffrey L Anderson; David P Faxon; Valentin Fuster; Jonathan L Halperin; Loren F Hiratzka; Sharon Ann Hunt; Alice K Jacobs; Rick Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel
Journal:  J Am Coll Cardiol       Date:  2006-01-03       Impact factor: 24.094

2.  Comparison of simple and complex stenting techniques in the treatment of unprotected left main coronary artery bifurcation stenosis.

Authors:  Young-Hak Kim; Seong-Wook Park; Myeong-Ki Hong; Duk-Woo Park; Kyoung-Min Park; Bong-Ki Lee; Jong-Min Song; Ki-Hoon Han; Cheol Whan Lee; Duk-Hyun Kang; Jae-Kwan Song; Jae-Joong Kim; Seung-Jung Park
Journal:  Am J Cardiol       Date:  2006-04-07       Impact factor: 2.778

3.  2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: 2007 Writing Group to Review New Evidence and Update the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention, Writing on Behalf of the 2005 Writing Committee.

Authors:  Spencer B King; Sidney C Smith; John W Hirshfeld; Alice K Jacobs; Douglass A Morrison; David O Williams; Ted E Feldman; Morton J Kern; William W O'Neill; Hartzell V Schaff; Patrick L Whitlow; Cynthia D Adams; Jeffrey L Anderson; Christopher E Buller; Mark A Creager; Steven M Ettinger; Jonathan L Halperin; Sharon A Hunt; Harlan M Krumholz; Frederick G Kushner; Bruce W Lytle; Rick Nishimura; Richard L Page; Barbara Riegel; Lynn G Tarkington; Clyde W Yancy
Journal:  Circulation       Date:  2007-12-13       Impact factor: 29.690

4.  Stents versus coronary-artery bypass grafting for left main coronary artery disease.

Authors:  Ki Bae Seung; Duk-Woo Park; Young-Hak Kim; Seung-Whan Lee; Cheol Whan Lee; Myeong-Ki Hong; Seong-Wook Park; Sung-Cheol Yun; Hyeon-Cheol Gwon; Myung-Ho Jeong; Yangsoo Jang; Hyo-Soo Kim; Pum Joon Kim; In-Whan Seong; Hun Sik Park; Taehoon Ahn; In-Ho Chae; Seung-Jea Tahk; Wook-Sung Chung; Seung-Jung Park
Journal:  N Engl J Med       Date:  2008-03-31       Impact factor: 91.245

5.  The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease.

Authors:  Georgios Sianos; Marie-Angèle Morel; Arie Pieter Kappetein; Marie-Claude Morice; Antonio Colombo; Keith Dawkins; Marcel van den Brand; Nic Van Dyck; Mary E Russell; Friedrich W Mohr; Patrick W Serruys
Journal:  EuroIntervention       Date:  2005-08       Impact factor: 6.534

6.  Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease.

Authors:  P W Serruys; F Unger; J E Sousa; A Jatene; H J Bonnier; J P Schönberger; N Buller; R Bonser; M J van den Brand; L A van Herwerden; M A Morel; B A van Hout
Journal:  N Engl J Med       Date:  2001-04-12       Impact factor: 91.245

7.  Cyphering the complexity of coronary artery disease using the syntax score to predict clinical outcome in patients with three-vessel lumen obstruction undergoing percutaneous coronary intervention.

Authors:  Marco Valgimigli; Patrick Washington Serruys; Keiichi Tsuchida; Sophia Vaina; Marie-Angèle Morel; Marcel J van den Brand; Antonio Colombo; Marie Claude Morice; Keith Dawkins; Bernard de Bruyne; Ran Kornowski; Stefano de Servi; Giulio Guagliumi; J Wouter Jukema; Frederick W Mohr; Arie-Pieter Kappetein; Kristel Wittebols; Hans-Peter Stoll; Eric Boersma; Giovanni Parrinello
Journal:  Am J Cardiol       Date:  2007-03-06       Impact factor: 2.778

8.  Percutaneous treatment with drug-eluting stent implantation versus bypass surgery for unprotected left main stenosis: a single-center experience.

Authors:  Alaide Chieffo; Nuccia Morici; Francesco Maisano; Erminio Bonizzoni; John Cosgrave; Matteo Montorfano; Flavio Airoldi; Mauro Carlino; Iassen Michev; Gloria Melzi; Giuseppe Sangiorgi; Ottavio Alfieri; Antonio Colombo
Journal:  Circulation       Date:  2006-05-22       Impact factor: 29.690

9.  Usefulness of SYNTAX score to select patients with left main coronary artery disease to be treated with coronary artery bypass graft.

Authors:  Davide Capodanno; Piera Capranzano; Maria Elena Di Salvo; Anna Caggegi; Davide Tomasello; Glauco Cincotta; Marco Miano; Martina Patané; Claudia Tamburino; Salvatore Tolaro; Leonardo Patané; Antonio Maria Calafiore; Corrado Tamburino
Journal:  JACC Cardiovasc Interv       Date:  2009-08       Impact factor: 11.195

10.  Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease.

Authors:  Patrick W Serruys; Marie-Claude Morice; A Pieter Kappetein; Antonio Colombo; David R Holmes; Michael J Mack; Elisabeth Ståhle; Ted E Feldman; Marcel van den Brand; Eric J Bass; Nic Van Dyck; Katrin Leadley; Keith D Dawkins; Friedrich W Mohr
Journal:  N Engl J Med       Date:  2009-02-18       Impact factor: 91.245

View more
  2 in total

Review 1.  Application of the SYNTAX score in interventional cardiology: A systematic review and meta-analysis.

Authors:  Pravesh Kumar Bundhun; Yashna Sookharee; Anita Bholee; Feng Huang
Journal:  Medicine (Baltimore)       Date:  2017-07       Impact factor: 1.889

2.  Adherence to guideline recommendations for coronary angiography in a poor South-East Asian setting: Impact on short- and medium-term clinical outcomes.

Authors:  Andriany Qanitha; Cuno S P M Uiterwaal; Jose P S Henriques; Idar Mappangara; Muzakkir Amir; Sumarsono G Saing; Bastianus A J M de Mol
Journal:  Sci Rep       Date:  2019-12-16       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.